The Board of Directors of Duopharma Biotech Berhad ("the Board") wishes to announce that it has undertaken a Board Committees review and benchmarking analysis on the governance framework of the Board Committees vis-à-vis the Board. Pursuant thereto, with effect from 1 July 2022, the structure of the Board Committees of Duopharma Biotech Berhad (the “Company”) has been revised as follows: -
|
Existing Structure
|
Revised Structure
|
Composition
|
| Audit and Integrity Committee |
Audit Committee
- Re-named to Audit Committee
- Integrity scope transferred to the Risk Management Committee
- No change in membership of the Committee
|
Chairman
1. Encik Razalee Bin Amin (Independent Non-Executive Director)
Members
1. Puan Zaiton Binti Jamaluddin (Independent Non-Executive Director)
2. Datuk Nik Moustpha Bin Hj Nik Hassan
(Independent Non-Executive Director)
|
| Risk Management and Sustainability Committee |
Risk Management Committee
- Re-named to Risk Management Committee
- Sustainability scope transferred to the Halal and Sustainability Committee
- Takes over the integrity scope that was formerly under the previous Audit and Integrity Committee
- No change in membership of the Committee
|
Chairman
1. Datuk Mohd Radzif Bin Mohd Yunus (Non-Independent Non-Executive Director)
Members
1. Puan Zaiton Binti Jamaluddin (Independent Non-Executive Director)
2. Dato’ Mohamad Kamarudin Bin Hassan (Senior Independent Non-Executive Director)
|
| Halal Committee |
Halal and Sustainability Committee
- Re-named to Halal and Sustainability Committee
- Takes over the sustainability scope that was formerly under the previous Risk Management and Sustainability Committee
- No change in membership of the Committee
|
Chairman
1. Datuk Nik Moustpha Bin Hj Nik Hassan
(Independent Non-Executive Director)
Members
1. Datuk Mohd Radzif Bin Mohd Yunus (Non-Independent Non-Executive Director)
2. Puan Amizar Binti Mizuar (Non-Independent Non-Executive Director)
|
| Medical Advisory Committee |
Medical and Research Committee
- Re-named to Medical and Research Committee
- No change in membership of the Committee
|
Chairman
1. Dato’ Dr Zaki Morad Bin Mohamad Zaher
(Independent Non-Executive Director)
Members
1. Dato’ Eisah Binti A. Rahman (Independent Non-Executive Director)
2. Dato’ Dr Mohamed Ibrahim A. Wahid (Non-Member of the Board of Directors)
3. Dr Ng Wai Kiat (Non-Member of the Board of Directors)
4. Dr Radhakrishna A. Sothiratnam (Non-Member of the Board of Directors)
5. Dato’ Dr Zanariah Binti Hussein (Non-Member of the Board of Directors)
|
| Nomination and Remuneration Committee |
No change
|
Chairman
1. Dato’ Mohamad Kamarudin Bin Hassan
(Senior Independent Non-Executive Director)
Member
1. Dato’ Eisah Binti A. Rahman (Independent Non-Executive Director)
2. Puan Amizar Binti Mizuar (Independent Non-Executive Director)
|
Arising from the aforesaid Board Committees Review, the Terms of Reference of the Committees have also been reviewed. Details of the Terms of Reference of the Board Committees under the new structure can be found on the Company’s website at www.duopharmabiotech.com.
This announcement is dated 1 July 2022.